CRISPR Therapeutics AG (CRSP)
Healthcare · Biotechnology
1 member of Congress has disclosed 4 trades in CRISPR Therapeutics AG (CRSP) since 2017: 1 buy and 3 sales. The most recent was disclosed on Jan 15, 2021.
- Trades disclosed
- 4
- Members trading
- 1
- Buys / sells
- 1 / 3
- Reported value
- $81K–$215K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at CRSP
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded CRSP
- Sen. James M. Inhofe (R-OK)1 buy · 3 sales13Jan 15, 2021
All trades
- Jan 15, 2021$1K–$15K
Sen. James M. Inhofe (R-OK)
Sold (partial) CRISPR Therapeutics AG CRSP
$1K–$15K · Traded Jan 5, 2021 · disclosed Jan 15, 2021
- Dec 23, 2020$50K–$100K
Sen. James M. Inhofe (R-OK)
Sold (partial) CRISPR Therapeutics AG CRSP
$50K–$100K · Traded Dec 22, 2020 · disclosed Dec 23, 2020
- Jun 20, 2018$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (partial) CRISPR Therapeutics AG CRSP
$15K–$50K · Traded Jun 19, 2018 · disclosed Jun 20, 2018
- Nov 8, 2017$15K–$50K
Sen. James M. Inhofe (R-OK)
Bought CRISPR Therapeutics AG CRSP
$15K–$50K · Traded Oct 19, 2017 · disclosed Nov 8, 2017
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.